2024 ICD-10-CM Diagnosis Code C62.90

Malignant neoplasm of unspecified testis, unspecified whether descended or undescended

ICD-10-CM Code:
C62.90
ICD-10 Code for:
Malig neoplasm of unsp testis, unsp descended or undescended
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:

Code Classification

  • Neoplasms
    (C00–D49)
    • Malignant neoplasms of male genital organs
      (C60-C63)
      • Malignant neoplasm of testis
        (C62)

C62.90 is a billable diagnosis code used to specify a medical diagnosis of malignant neoplasm of unspecified testis, unspecified whether descended or undescended. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

This code is applicable to male patients only. It is clinically and virtually impossible to use this code on a non-male patient.

The following anatomical sites found in the Table of Neoplasms reference the parent code C62.9 of the current diagnosis code given the correct histological behavior: Neoplasm, neoplastic testis, testes or Neoplasm, neoplastic testis, testes unspecified whether descended or undescended .

Unspecified diagnosis codes like C62.90 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Choriocarcinoma
  • Choriocarcinoma
  • Embryonal carcinoma
  • Embryonal carcinoma
  • Germ cell tumor of testis
  • Malignant germ cell tumor of testis
  • Malignant granulosa cell tumor of testis
  • Malignant Leydig cell tumor of testis
  • Malignant sex cord tumor of testis
  • Malignant teratoma
  • Malignant teratoma of testis
  • Malignant tumor of testis
  • Mixed germ cell tumor
  • Mixed seminoma teratoma of testis
  • Non-seminomatous germ cell neoplasm of testis
  • NUT carcinoma
  • Paratesticular adenocarcinoma
  • Paratesticular malignant neoplasm
  • Polyembryoma
  • Primary choriocarcinoma of testis
  • Primary embryonal carcinoma of testis
  • Primary malignant granulosa cell tumor of testis
  • Primary malignant Leydig cell tumor of testis
  • Primary malignant neoplasm of testis
  • Primary malignant sex cord tumor of testis
  • Regressed malignant testicular tumor
  • Seminoma
  • Seminoma of testis
  • Seminoma of testis, stage 1
  • Seminoma of testis, stage 2
  • Seminoma of testis, stage 3
  • Seminoma of testis, stage 4
  • Spermatocytic seminoma of testis
  • Teratoma of testis
  • Yolk sac tumor

Clinical Classification

Clinical Information

  • Choriocarcinoma

    a malignant metastatic form of trophoblastic tumors. unlike the hydatidiform mole, choriocarcinoma contains no chorionic villi but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (trophoblasts). it is characterized by the large amounts of chorionic gonadotropin produced. tissue origins can be determined by dna analyses: placental (fetal) origin or non-placental origin (choriocarcinoma, non-gestational).
  • Choriocarcinoma, Non-gestational

    a highly malignant choriocarcinoma derived from the non-placental origin such as the totipotent cells in the testis, the ovary, and the pineal gland. it produces high levels of chorionic gonadotropin and can metastasize widely through the bloodstream to the lungs, brain, liver, bone, and other viscera by the time of diagnosis.
  • Seminoma

    a radiosensitive, malignant neoplasm of the testis, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. there are three variants: classical (typical), the most common type; anaplastic; and spermatocytic. the classical seminoma is composed of fairly well differentiated sheets or cords of uniform polygonal or round cells (seminoma cells), each cell having abundant clear cytoplasm, distinct cell membranes, a centrally placed round nucleus, and one or more nucleoli. in the female, a grossly and histologically identical neoplasm, known as dysgerminoma, occurs. (dorland, 27th ed)

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.


Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Malignant neoplasm of testis NOS

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10-CM Code Edits are applicable to this code:

  • Diagnoses for males only - The Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, these edits apply to MALES only .

Convert C62.90 to ICD-9-CM

  • ICD-9-CM Code: 186.9 - Malig neo testis NEC
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Table of Neoplasms

The parent code C62.9 of the current diagnosis code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »testis, testes
C62.9C79.82D07.69D29.2D40.1D49.59
»Neoplasm, neoplastic
  »testis, testes
    »unspecified whether descended or undescended
C62.9C79.82D07.69D29.2D40.1D49.59

Patient Education


Testicular Cancer

What is testicular cancer?

Testicular cancer is a cancer that develops in the tissues of one or both testicles. The testicles, or testes, are part of the male reproductive system. They make male hormones and sperm. They are two egg-shaped glands inside the scrotum, a sac of loose skin that lies below the penis. You can get cancer in one or both testicles.

Who is most likely to develop testicular cancer?

Testicular cancer is very rare. You can get it at any age, but it is most common in men between the ages of 20 and 39. It is also more common in those who:

  • Have had abnormal testicle development
  • Have had an undescended testicle, a condition in which one or both testicles fail to move into the scrotum before birth
  • Have had testicle cancer before
  • Have a family history of the cancer
  • Are White

What are the symptoms of testicular cancer?

The symptoms of testicular cancer may include:

  • A painless lump or swelling in either testicle
  • A change in how the testicle feels
  • A dull ache in the lower abdomen (belly) or the groin (the area where the thigh meets the abdomen)
  • A sudden build-up of fluid in the scrotum
  • Pain or discomfort in a testicle or in the scrotum

How is testicular cancer diagnosed?

To find out if you have testicular cancer, your health care provider may use:

  • A physical exam.
  • Blood tests.
  • An ultrasound of the testicles.
  • An inguinal orchiectomy, which is a procedure to remove the entire testicle. A tissue sample from the testicle is viewed under a microscope to check for cancer cells.

What are the treatments for testicular cancer?

Testicular cancer can usually be cured.The treatment options include:

  • Surgery (if the testicle has not already been removed during diagnosis).
  • Radiation therapy.
  • Chemotherapy.
  • High-dose chemotherapy with stem cell transplant.
  • Surveillance, which might be done after surgery. It means that your provider will closely follow your condition with regular exams and tests. You won't get any further treatment unless there are changes in your test results.

Some of the treatments may also cause infertility. If you may want to have children later on, you should consider sperm banking before treatment.

After you have finished your treatment, you will need regular follow-up testing to make sure that the cancer has not come back. If you have had cancer in one testicle, you have a higher risk of getting cancer in the other testicle. So it's important to check the other testicle regularly and let your provider know if you notice any changes or unusual symptoms.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Testicular Cancer Treatment (PDQ®)

Learn about testicular cancer risk factors, signs and symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.